Matches in Wikidata for { <http://www.wikidata.org/entity/Q61921200> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q61921200 description "assaig clínic" @default.
- Q61921200 description "clinical trial" @default.
- Q61921200 description "clinical trial" @default.
- Q61921200 description "clinical trial" @default.
- Q61921200 description "clinical trial" @default.
- Q61921200 description "ensaio clínico" @default.
- Q61921200 description "ensayo clínico" @default.
- Q61921200 description "ensayu clínicu" @default.
- Q61921200 description "essai clinique" @default.
- Q61921200 description "klinisch onderzoek" @default.
- Q61921200 description "клінічне випробування" @default.
- Q61921200 description "临床试验" @default.
- Q61921200 name "Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer" @default.
- Q61921200 type Item @default.
- Q61921200 label "Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer" @default.
- Q61921200 prefLabel "Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer" @default.
- Q61921200 P1132 Q61921200-00C48A86-F5BF-485B-BA56-369F7BBA3D2C @default.
- Q61921200 P1476 Q61921200-EDDFAFFC-40B0-4D54-8D8A-59B10AF9F1C3 @default.
- Q61921200 P17 Q61921200-5DC03AE0-40D8-4B37-9551-C80A5AE9F84C @default.
- Q61921200 P17 Q61921200-B447EEFB-4523-4143-A255-413FAA800A44 @default.
- Q61921200 P17 Q61921200-C80F7D2C-6CF8-4425-ADA1-1AE7ED3337D2 @default.
- Q61921200 P1813 Q61921200-9280CC75-CD7E-40C4-A1A4-87F645F7BA4E @default.
- Q61921200 P2899 Q61921200-7E964B82-4BD5-4221-AF9A-6BD04A3AF6B5 @default.
- Q61921200 P3098 Q61921200-F99F55EB-4DA8-43C7-8930-88881B069B22 @default.
- Q61921200 P31 Q61921200-D7CA61EA-C18A-4185-82A0-05247EB4CF10 @default.
- Q61921200 P4135 Q61921200-CD53E8C2-1AB1-41E2-905E-46A6A2DEEF63 @default.
- Q61921200 P4844 Q61921200-0B075378-95A6-4656-A5F1-8843DA4F5118 @default.
- Q61921200 P4844 Q61921200-1DC54525-C0CB-425D-9A5C-0A8D906370C9 @default.
- Q61921200 P4844 Q61921200-5DE1333E-8163-4102-AC4E-7BF52EA03ADB @default.
- Q61921200 P4844 Q61921200-D3F2DCC9-9E6C-4591-91F3-EDEBE42942BF @default.
- Q61921200 P4844 Q61921200-E91D39D8-B3BF-415D-BE5A-CA78FA92D0B2 @default.
- Q61921200 P580 Q61921200-14D64F51-8D81-400B-824E-E108FEE05CD2 @default.
- Q61921200 P582 Q61921200-A1877F64-C8CB-4D98-A2B6-3B71C78AA5A0 @default.
- Q61921200 P6099 Q61921200-76E1B9BD-C235-464C-8099-E4E1F46E979D @default.
- Q61921200 P6153 Q61921200-9BF73450-D8C8-4268-B884-602CA4064A1C @default.
- Q61921200 P8005 Q61921200-4949CA7C-F240-44EE-9760-85FB389C905F @default.
- Q61921200 P8363 Q61921200-37F2DF8F-4D9C-4106-96EC-A65BAC9C55D6 @default.
- Q61921200 P859 Q61921200-55A068D3-97B4-4D62-BF19-8CF818D76862 @default.
- Q61921200 P1132 "+121" @default.
- Q61921200 P1476 "Chemotherapy Plus Lapatinib or Trastuzumab or Both in Her2+ Primary Breast Cancer. A Randomized Phase IIb Study With Biomarker Evaluation." @default.
- Q61921200 P17 Q183 @default.
- Q61921200 P17 Q36 @default.
- Q61921200 P17 Q38 @default.
- Q61921200 P1813 "CHERLOB" @default.
- Q61921200 P2899 "+18" @default.
- Q61921200 P3098 "NCT00429299" @default.
- Q61921200 P31 Q30612 @default.
- Q61921200 P4135 "+65" @default.
- Q61921200 P4844 Q238512 @default.
- Q61921200 P4844 Q408524 @default.
- Q61921200 P4844 Q412616 @default.
- Q61921200 P4844 Q420323 @default.
- Q61921200 P4844 Q425122 @default.
- Q61921200 P580 "2006-08-01T00:00:00Z" @default.
- Q61921200 P582 "2012-06-01T00:00:00Z" @default.
- Q61921200 P6099 Q42824440 @default.
- Q61921200 P6153 Q212322 @default.
- Q61921200 P8005 Q76651189 @default.
- Q61921200 P8363 Q78089383 @default.
- Q61921200 P859 Q212322 @default.